- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide – November 2015
Elvitegravir with cobicistat, emtricitabine and tenofovir alafenamide, fixed-dose combination tablet, 150 mg/ 150 mg/200 mg/10 mg, Genvoya®
Last updated
4 March 2016